speb/financial-data huggingface dataset:
ICRS.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -114762.00
ICRS.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -114762.00
ICRS.V cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -114763.00
ICRS.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -114762.00
ICRS.V income_statement (quarterly, 2025-06-30) — Net Interest Income: -24058.00
ICRS.V cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -66411.00
ICRS.V cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -44071.00
ICRS.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -24058.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Net PPE: 240723.00
ICRS.V cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -22340.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -318623.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 10500.00
ICRS.V income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -72597.00
ICRS.V income_statement (quarterly, 2025-06-30) — Normalized Income: -114762.00
ICRS.V cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -24796.00
ICRS.V income_statement (quarterly, 2025-06-30) — Operating Income: -90704.00
ICRS.V income_statement (quarterly, 2025-06-30) — Operating Revenue: 250339.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 8577827.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 151026.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 212092.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 33048.00
ICRS.V income_statement (quarterly, 2025-06-30) — Other Gand A: 128846.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 35667.00
ICRS.V cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 37721.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: -25002.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Other Properties: 240723.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Payables: 149096.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 149096.00
ICRS.V income_statement (quarterly, 2025-06-30) — Pretax Income: -114762.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Receivables: 5400.00
ICRS.V income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 203386.00
ICRS.V income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 18107.00
ICRS.V cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -31293.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -942849.00
ICRS.V income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 8811.00
ICRS.V income_statement (quarterly, 2025-06-30) — Selling General And Administration: 137657.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Share Issued: 8577827.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -282956.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -318623.00
ICRS.V income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ICRS.V income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Total Assets: 450693.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -93829.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Total Debt: 584553.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -282956.00
ICRS.V income_statement (quarterly, 2025-06-30) — Total Expenses: 341043.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 733649.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 286890.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 376217.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 11203.00
ICRS.V balance_sheet (quarterly, 2025-06-30) — Working Capital: -193629.00
ICRS.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 149410.00
ICRS.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 269064.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 85898.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 7168.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 57321.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 18586.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 18586.00
ICRS.V income_statement (quarterly, 2025-09-30) — Basic Average Shares: 8577827.00
ICRS.V income_statement (quarterly, 2025-09-30) — Basic EPS: -0.01
ICRS.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 148179.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 229538.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 569524.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 87962.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 87962.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Cash Financial: 87962.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -55869.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -4348.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 7353.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: -60217.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 569524.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -334713.00
ICRS.V income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 153608.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 116102.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 56374.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Current Debt: 201575.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 257949.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 359735.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 18586.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 18586.00
ICRS.V income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 8577827.00
ICRS.V income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.01
ICRS.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -51757.00
ICRS.V income_statement (quarterly, 2025-09-30) — EBIT: -33954.00
ICRS.V income_statement (quarterly, 2025-09-30) — EBITDA: -15368.00
ICRS.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 87962.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -55869.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -4348.00
ICRS.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 145043.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 32917.00
ICRS.V income_statement (quarterly, 2025-09-30) — Gross Profit: 115456.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 1166.00
ICRS.V income_statement (quarterly, 2025-09-30) — Interest Expense: 17803.00
ICRS.V income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 17803.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Inventory: 10472.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: 42582.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 0.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 173164.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 175720.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 348884.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -25169.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Net Debt: 289333.00
ICRS.V income_statement (quarterly, 2025-09-30) — Net Income: -51757.00
ICRS.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -51757.00
ICRS.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -51757.00
ICRS.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -51757.00
ICRS.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -51757.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -51757.00
ICRS.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -51757.00
ICRS.V income_statement (quarterly, 2025-09-30) — Net Interest Income: -17803.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -25169.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -25169.00
ICRS.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -17803.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -8788.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 224887.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 0.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -367630.00
ICRS.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -15368.00
ICRS.V income_statement (quarterly, 2025-09-30) — Normalized Income: -51757.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -4348.00
ICRS.V income_statement (quarterly, 2025-09-30) — Operating Income: -33954.00
ICRS.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 269064.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 8577827.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 201575.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 33048.00
ICRS.V income_statement (quarterly, 2025-09-30) — Other Gand A: 145043.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 21470.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Payables: 101786.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 101786.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 10500.00
ICRS.V income_statement (quarterly, 2025-09-30) — Pretax Income: -51757.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Receivables: 7168.00
ICRS.V income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 153608.00
ICRS.V income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 18586.00
ICRS.V cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -25169.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -994606.00
ICRS.V income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 4367.00
ICRS.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 149410.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 8577827.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -334713.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -367630.00
ICRS.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ICRS.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 373906.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -158993.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 606833.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -334713.00
ICRS.V income_statement (quarterly, 2025-09-30) — Total Expenses: 303018.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 708619.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 257804.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 348884.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 15888.00
ICRS.V balance_sheet (quarterly, 2025-09-30) — Working Capital: -243633.00
ICRS.V income_statement (annual, 2025-12-31) — +Operating Expense: 606862.00
ICRS.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 211462.00
ICRS.V income_statement (annual, 2025-12-31) — +Total Revenue: 1445519.00
ICRS.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 509812.00
ICRS.V balance_sheet (annual, 2025-12-31) — Accounts Payable: 114039.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 114039.00
ICRS.V balance_sheet (annual, 2025-12-31) — Accounts Receivable: 12085.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 12085.00
ICRS.V cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
ICRS.V income_statement (annual, 2025-12-31) — Basic Average Shares: 8577827.00
ICRS.V income_statement (annual, 2025-12-31) — Basic EPS: -0.02
ICRS.V cash_flow (annual, 2025-12-31) — Beginning Cash Position: 51500.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 87962.00
ICRS.V balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 214527.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 214527.00
ICRS.V balance_sheet (annual, 2025-12-31) — Capital Stock: 569524.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 569524.00
ICRS.V balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 55348.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 55348.00
ICRS.V balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 55348.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 55348.00
ICRS.V cash_flow (annual, 2025-12-31) — Cash Dividends Paid: 0.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
ICRS.V balance_sheet (annual, 2025-12-31) — Cash Financial: 55348.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Cash Financial: 55348.00
ICRS.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -29281.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -36262.00
ICRS.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 33129.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3648.00
ICRS.V cash_flow (annual, 2025-12-31) — Change In Working Capital: 18529.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 5534.00
ICRS.V cash_flow (annual, 2025-12-31) — Changes In Cash: 3848.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: -32614.00
ICRS.V balance_sheet (annual, 2025-12-31) — Common Stock: 569524.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 569524.00
ICRS.V balance_sheet (annual, 2025-12-31) — Common Stock Equity: -370129.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -370129.00
ICRS.V income_statement (annual, 2025-12-31) — Cost Of Revenue: 899268.00
ICRS.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 320812.00
ICRS.V balance_sheet (annual, 2025-12-31) — Current Assets: 81342.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 81342.00
ICRS.V balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 55428.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 55428.00
ICRS.V balance_sheet (annual, 2025-12-31) — Current Debt: 151944.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Current Debt: 151944.00
ICRS.V balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 207372.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 207372.00
ICRS.V balance_sheet (annual, 2025-12-31) — Current Liabilities: 380046.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 380046.00
ICRS.V cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 73865.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 18586.00
ICRS.V cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 73865.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 18586.00
ICRS.V income_statement (annual, 2025-12-31) — Diluted Average Shares: 8577827.00
ICRS.V income_statement (annual, 2025-12-31) — Diluted EPS: -0.02
ICRS.V income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -134182.00
ICRS.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -35416.00
ICRS.V balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 36108.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 36108.00
ICRS.V income_statement (annual, 2025-12-31) — EBIT: -60611.00
ICRS.V income_statement (quarterly, 2025-12-31) — EBIT: -22462.00
ICRS.V income_statement (annual, 2025-12-31) — EBITDA: 13254.00
ICRS.V income_statement (quarterly, 2025-12-31) — EBITDA: -3876.00
ICRS.V cash_flow (annual, 2025-12-31) — End Cash Position: 55348.00
ICRS.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 55348.00
ICRS.V cash_flow (annual, 2025-12-31) — Financing Cash Flow: -29281.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -36262.00
ICRS.V cash_flow (annual, 2025-12-31) — Free Cash Flow: 33129.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 3648.00
ICRS.V income_statement (annual, 2025-12-31) — General And Administrative Expense: 566147.00
ICRS.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 199341.00
ICRS.V balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 30167.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 30167.00
ICRS.V balance_sheet (annual, 2025-12-31) — Gross PPE: 209051.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 209051.00
ICRS.V income_statement (annual, 2025-12-31) — Gross Profit: 546251.00
ICRS.V income_statement (quarterly, 2025-12-31) — Gross Profit: 189000.00
ICRS.V income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
ICRS.V balance_sheet (annual, 2025-12-31) — Income Tax Payable: 9190.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 9190.00
ICRS.V income_statement (annual, 2025-12-31) — Interest Expense: 64381.00
ICRS.V income_statement (quarterly, 2025-12-31) — Interest Expense: 3764.00
ICRS.V income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 64381.00
ICRS.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 3764.00
ICRS.V cash_flow (annual, 2025-12-31) — Interest Paid Cff: -27595.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -5683.00
ICRS.V balance_sheet (annual, 2025-12-31) — Inventory: 13909.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Inventory: 13909.00
ICRS.V balance_sheet (annual, 2025-12-31) — Invested Capital: -56141.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: -56141.00
ICRS.V balance_sheet (annual, 2025-12-31) — Line Of Credit: 0.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 0.00
ICRS.V balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 159099.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 159099.00
ICRS.V balance_sheet (annual, 2025-12-31) — Long Term Debt: 162044.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 162044.00
ICRS.V balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 321143.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 321143.00
ICRS.V cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -141318.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -39688.00
ICRS.V balance_sheet (annual, 2025-12-31) — Net Debt: 258640.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Net Debt: 258640.00
ICRS.V income_statement (annual, 2025-12-31) — Net Income: -134182.00
ICRS.V income_statement (quarterly, 2025-12-31) — Net Income: -35416.00
ICRS.V income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -134182.00
ICRS.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -35416.00
ICRS.V income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -134182.00
ICRS.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -35416.00
ICRS.V income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -134182.00
ICRS.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -35416.00
ICRS.V income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -134182.00
ICRS.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -35416.00
ICRS.V cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -134182.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -35416.00
ICRS.V income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -134182.00
ICRS.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -35416.00
ICRS.V income_statement (annual, 2025-12-31) — Net Interest Income: -64381.00
ICRS.V income_statement (quarterly, 2025-12-31) — Net Interest Income: -3764.00
ICRS.V cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -176436.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -39688.00
ICRS.V cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -141318.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -39688.00
ICRS.V income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -64381.00
ICRS.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -3764.00
ICRS.V cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -2250.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 6859.00
ICRS.V balance_sheet (annual, 2025-12-31) — Net PPE: 209051.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 209051.00
ICRS.V cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -35118.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 0.00
ICRS.V balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -400296.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -400296.00
ICRS.V balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 10500.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 10500.00
ICRS.V income_statement (annual, 2025-12-31) — Normalized EBITDA: 13254.00
ICRS.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -3876.00
ICRS.V income_statement (annual, 2025-12-31) — Normalized Income: -134182.00
ICRS.V income_statement (quarterly, 2025-12-31) — Normalized Income: -35416.00
ICRS.V cash_flow (annual, 2025-12-31) — Operating Cash Flow: 33129.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 3648.00
ICRS.V income_statement (annual, 2025-12-31) — Operating Income: -60611.00
ICRS.V income_statement (quarterly, 2025-12-31) — Operating Income: -22462.00
ICRS.V income_statement (annual, 2025-12-31) — Operating Revenue: 1445519.00
ICRS.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 509812.00
ICRS.V balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 8577827.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 8577827.00
ICRS.V balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 151944.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 151944.00
ICRS.V balance_sheet (annual, 2025-12-31) — Other Equity Interest: 90369.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 90369.00
ICRS.V income_statement (annual, 2025-12-31) — Other Gand A: 566147.00
ICRS.V income_statement (quarterly, 2025-12-31) — Other Gand A: 199341.00
ICRS.V balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 30167.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 30167.00
ICRS.V cash_flow (annual, 2025-12-31) — Other Non Cash Items: 74917.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 14944.00
ICRS.V balance_sheet (annual, 2025-12-31) — Other Properties: 209051.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Other Properties: 209051.00
ICRS.V balance_sheet (annual, 2025-12-31) — Payables: 172674.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Payables: 172674.00
ICRS.V balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 172674.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 172674.00
ICRS.V income_statement (annual, 2025-12-31) — Pretax Income: -124992.00
ICRS.V income_statement (quarterly, 2025-12-31) — Pretax Income: -26226.00
ICRS.V cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 177000.00
ICRS.V balance_sheet (annual, 2025-12-31) — Receivables: 12085.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Receivables: 12085.00
ICRS.V income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 899268.00
ICRS.V income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 320812.00
ICRS.V income_statement (annual, 2025-12-31) — Reconciled Depreciation: 73865.00
ICRS.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 18586.00
ICRS.V cash_flow (annual, 2025-12-31) — Repayment Of Debt: -141318.00
ICRS.V cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -39688.00
ICRS.V balance_sheet (annual, 2025-12-31) — Retained Earnings: -1030022.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1030022.00
ICRS.V income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 40715.00
ICRS.V income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 12121.00
ICRS.V income_statement (annual, 2025-12-31) — Selling General And Administration: 606862.00
ICRS.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 211462.00
ICRS.V balance_sheet (annual, 2025-12-31) — Share Issued: 8577827.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 8577827.00
ICRS.V income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
ICRS.V balance_sheet (annual, 2025-12-31) — Stockholders Equity: -370129.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -370129.00
ICRS.V balance_sheet (annual, 2025-12-31) — Tangible Book Value: -400296.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -400296.00
ICRS.V income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ICRS.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ICRS.V income_statement (annual, 2025-12-31) — Tax Provision: 9190.00
ICRS.V income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
ICRS.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
ICRS.V balance_sheet (annual, 2025-12-31) — Total Assets: 331060.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 331060.00
ICRS.V balance_sheet (annual, 2025-12-31) — Total Capitalization: -208085.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -208085.00
ICRS.V balance_sheet (annual, 2025-12-31) — Total Debt: 528515.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 528515.00
ICRS.V balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -370129.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -370129.00
ICRS.V income_statement (annual, 2025-12-31) — Total Expenses: 1506130.00
ICRS.V income_statement (quarterly, 2025-12-31) — Total Expenses: 532274.00
ICRS.V balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 701189.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 701189.00
ICRS.V balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 249718.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 249718.00
ICRS.V balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 321143.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 321143.00
ICRS.V balance_sheet (annual, 2025-12-31) — Total Tax Payable: 22527.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 22527.00
ICRS.V income_statement (annual, 2025-12-31) — Total Unusual Items: 0.00
ICRS.V income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
ICRS.V balance_sheet (annual, 2025-12-31) — Working Capital: -298704.00
ICRS.V balance_sheet (quarterly, 2025-12-31) — Working Capital: -298704.00
ICRS.V income_statement (quarterly, 2026-03-31) — +Operating Expense: 182492.00
ICRS.V income_statement (quarterly, 2026-03-31) — +Total Revenue: 590203.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 114767.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 30210.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 17004.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 17004.00
ICRS.V income_statement (quarterly, 2026-03-31) — Basic Average Shares: 8577827.00
ICRS.V income_statement (quarterly, 2026-03-31) — Basic EPS: 0.01
ICRS.V cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 55348.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 200877.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Capital Stock: 569524.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 130597.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 130597.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Cash Financial: 130597.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -31646.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 106897.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -4553.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Changes In Cash: 75249.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Common Stock: 569524.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -277805.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 2.00
ICRS.V income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 299369.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Current Assets: 174716.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 55984.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Current Debt: 150022.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 206006.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 392252.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 17004.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 17004.00
ICRS.V income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 8577827.00
ICRS.V income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.01
ICRS.V income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 92324.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 41273.00
ICRS.V income_statement (quarterly, 2026-03-31) — EBIT: 108342.00
ICRS.V income_statement (quarterly, 2026-03-31) — EBITDA: 125346.00
ICRS.V cash_flow (quarterly, 2026-03-31) — End Cash Position: 130597.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -31648.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 106897.00
ICRS.V income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 163080.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 27417.00
ICRS.V income_statement (quarterly, 2026-03-31) — Gross Profit: 290834.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 9190.00
ICRS.V income_statement (quarterly, 2026-03-31) — Interest Expense: 6828.00
ICRS.V income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 6828.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Inventory: 13909.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Invested Capital: 20299.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 2.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 144893.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 148082.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 292975.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -31648.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 2.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Net Debt: 167507.00
ICRS.V income_statement (quarterly, 2026-03-31) — Net Income: 92324.00
ICRS.V income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 92324.00
ICRS.V income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 101514.00
ICRS.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 92324.00
ICRS.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 92324.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 92324.00
ICRS.V income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 101514.00
ICRS.V income_statement (quarterly, 2026-03-31) — Net Interest Income: -6828.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -31648.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -31648.00
ICRS.V income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -6828.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -2.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Net PPE: 194798.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 0.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -305222.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 10491.00
ICRS.V income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 125346.00
ICRS.V income_statement (quarterly, 2026-03-31) — Normalized Income: 92324.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 106897.00
ICRS.V income_statement (quarterly, 2026-03-31) — Operating Income: 108342.00
ICRS.V income_statement (quarterly, 2026-03-31) — Operating Revenue: 590203.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 8577827.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 150022.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 90369.00
ICRS.V income_statement (quarterly, 2026-03-31) — Other Gand A: 163080.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 2122.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Payables: 186246.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 186246.00
ICRS.V income_statement (quarterly, 2026-03-31) — Pretax Income: 101514.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Receivables: 30210.00
ICRS.V income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 299369.00
ICRS.V income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 17004.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -31648.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -937698.00
ICRS.V income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 19412.00
ICRS.V income_statement (quarterly, 2026-03-31) — Selling General And Administration: 182492.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Share Issued: 8577827.00
ICRS.V cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: 0.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -277805.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -305222.00
ICRS.V income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ICRS.V income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
ICRS.V balance_sheet (quarterly, 2026-03-31) — Total Assets: 407422.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Total Capitalization: -129723.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Total Debt: 498981.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -277805.00
ICRS.V income_statement (quarterly, 2026-03-31) — Total Expenses: 481861.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 685227.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 232706.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 292975.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 30206.00
ICRS.V balance_sheet (quarterly, 2026-03-31) — Working Capital: -217536.00
ICU cash_flow (annual, 2021-12-31) — Change In Inventory: 55000.00
ICU cash_flow (annual, 2021-12-31) — Change In Other Current Assets: 0.00
ICU balance_sheet (annual, 2021-12-31) — Current Notes Payable: 0.00
ICU balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 55000.00
ICU balance_sheet (annual, 2021-12-31) — Financial Assets: 0.00
ICU cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 0.00
ICU income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 0.00
ICU balance_sheet (annual, 2021-12-31) — Interest Payable: 72000.00
ICU balance_sheet (annual, 2021-12-31) — Inventory: 0.00
ICU balance_sheet (annual, 2021-12-31) — Long Term Debt: 244000.00
ICU balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 244000.00
ICU balance_sheet (annual, 2021-12-31) — Net Debt: 2112000.00
ICU cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 0.00
ICU income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 91000.00
ICU balance_sheet (annual, 2021-12-31) — Other Receivables: 58000.00
ICU balance_sheet (annual, 2021-12-31) — Preferred Securities Outside Stock Equity: 73349000.00
ICU cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 0.00
ICU income_statement (annual, 2021-12-31) — Special Income Charges: 0.00
ICU income_statement (annual, 2022-12-31) — +Operating Expense: 11609000.00
ICU income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
ICU balance_sheet (annual, 2022-12-31) — Accounts Payable: 1927000.00
ICU balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 67739000.00
ICU income_statement (annual, 2022-12-31) — Basic Average Shares: 32845.00
ICU income_statement (annual, 2022-12-31) — Basic EPS: -700.00
ICU cash_flow (annual, 2022-12-31) — Beginning Cash Position: 510000.00
ICU balance_sheet (annual, 2022-12-31) — Capital Stock: 1000.00
ICU balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 47000.00
ICU balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 47000.00
ICU balance_sheet (annual, 2022-12-31) — Cash Financial: 47000.00
ICU cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 7331000.00
ICU cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -7794000.00
ICU cash_flow (annual, 2022-12-31) — Change In Account Payable: 1548000.00
ICU cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 2073000.00
ICU cash_flow (annual, 2022-12-31) — Change In Inventory: 0.00
ICU cash_flow (annual, 2022-12-31) — Change In Payable: 1548000.00
ICU cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 3621000.00
ICU cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -1073000.00
ICU cash_flow (annual, 2022-12-31) — Change In Receivables: 4000.00
ICU cash_flow (annual, 2022-12-31) — Change In Working Capital: 2552000.00
ICU cash_flow (annual, 2022-12-31) — Changes In Cash: -463000.00
ICU balance_sheet (annual, 2022-12-31) — Common Stock: 1000.00
ICU balance_sheet (annual, 2022-12-31) — Common Stock Equity: -20762000.00
ICU cash_flow (annual, 2022-12-31) — Common Stock Issuance: 10001000.00
ICU balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 2245000.00
ICU balance_sheet (annual, 2022-12-31) — Current Assets: 1519000.00
ICU balance_sheet (annual, 2022-12-31) — Current Debt: 1178000.00
ICU balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 1178000.00
ICU balance_sheet (annual, 2022-12-31) — Current Liabilities: 16148000.00
ICU balance_sheet (annual, 2022-12-31) — Current Notes Payable: 1178000.00
ICU balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 0.00
ICU income_statement (annual, 2022-12-31) — Diluted Average Shares: 32845.00
ICU income_statement (annual, 2022-12-31) — Diluted EPS: -700.00
ICU income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -12190000.00
ICU income_statement (annual, 2022-12-31) — EBIT: -11559000.00
ICU income_statement (annual, 2022-12-31) — EBITDA: -11559000.00
ICU cash_flow (annual, 2022-12-31) — End Cash Position: 47000.00
ICU balance_sheet (annual, 2022-12-31) — Financial Assets: 1729000.00
ICU cash_flow (annual, 2022-12-31) — Financing Cash Flow: 7331000.00
ICU cash_flow (annual, 2022-12-31) — Free Cash Flow: -7794000.00
ICU cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -50000.00
ICU income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 50000.00
ICU income_statement (annual, 2022-12-31) — General And Administrative Expense: 6916000.00
ICU cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 1000.00
ICU income_statement (annual, 2022-12-31) — Interest Expense: 630000.00
ICU income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 630000.00
ICU cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 6000.00
ICU balance_sheet (annual, 2022-12-31) — Interest Payable: 112000.00
ICU balance_sheet (annual, 2022-12-31) — Invested Capital: -11932000.00
ICU cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 10001000.00
ICU cash_flow (annual, 2022-12-31) — Issuance Of Debt: 3559000.00
ICU balance_sheet (annual, 2022-12-31) — Long Term Debt: 7652000.00
ICU balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 7652000.00
ICU cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 3559000.00
ICU cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -78000.00
ICU cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 10001000.00
ICU balance_sheet (annual, 2022-12-31) — Net Debt: 8783000.00
ICU income_statement (annual, 2022-12-31) — Net Income: -12190000.00
ICU income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -12190000.00
ICU income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -12190000.00
ICU income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -12190000.00
ICU income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -12190000.00
ICU cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -12190000.00
ICU income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -12190000.00
ICU income_statement (annual, 2022-12-31) — Net Interest Income: -630000.00
ICU cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 3481000.00
ICU cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 3481000.00
ICU income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -630000.00
ICU cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -1211000.00
ICU balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -20762000.00
ICU income_statement (annual, 2022-12-31) — Normalized EBITDA: -11609000.00
ICU income_statement (annual, 2022-12-31) — Normalized Income: -12240000.00
ICU cash_flow (annual, 2022-12-31) — Operating Cash Flow: -7794000.00
ICU cash_flow (annual, 2022-12-31) — Operating Gains Losses: -50000.00
ICU income_statement (annual, 2022-12-31) — Operating Income: -11609000.00
ICU income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
ICU balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 50798.00
ICU balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 1178000.00
ICU balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 10798000.00
ICU income_statement (annual, 2022-12-31) — Other Gand A: 6916000.00
ICU income_statement (annual, 2022-12-31) — Other Income Expense: 50000.00
ICU cash_flow (annual, 2022-12-31) — Other Non Cash Items: 583000.00
ICU balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1519000.00
ICU income_statement (annual, 2022-12-31) — Other Operating Expenses: 2190000.00
ICU balance_sheet (annual, 2022-12-31) — Other Receivables: 12000.00
ICU balance_sheet (annual, 2022-12-31) — Payables: 1927000.00
ICU balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 4172000.00
ICU balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
ICU balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1460000.00
ICU income_statement (annual, 2022-12-31) — Pretax Income: -12189000.00
ICU cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: -4940000.00
ICU balance_sheet (annual, 2022-12-31) — Receivables: 12000.00
ICU cash_flow (annual, 2022-12-31) — Repayment Of Debt: -78000.00
ICU income_statement (annual, 2022-12-31) — Research And Development: 2503000.00
ICU balance_sheet (annual, 2022-12-31) — Retained Earnings: -88502000.00
ICU income_statement (annual, 2022-12-31) — Selling General And Administration: 6916000.00
ICU balance_sheet (annual, 2022-12-31) — Share Issued: 50798.00
ICU income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
ICU cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1311000.00
ICU balance_sheet (annual, 2022-12-31) — Stockholders Equity: -20762000.00
ICU balance_sheet (annual, 2022-12-31) — Tangible Book Value: -20762000.00
ICU income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
ICU income_statement (annual, 2022-12-31) — Tax Provision: 1000.00
ICU income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
ICU balance_sheet (annual, 2022-12-31) — Total Assets: 3038000.00
ICU balance_sheet (annual, 2022-12-31) — Total Capitalization: -13110000.00
ICU balance_sheet (annual, 2022-12-31) — Total Debt: 8830000.00
ICU balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -20762000.00
ICU income_statement (annual, 2022-12-31) — Total Expenses: 11609000.00
ICU balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 23800000.00
ICU balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1519000.00
ICU balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 7652000.00
ICU income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -11609000.00
ICU income_statement (annual, 2022-12-31) — Total Unusual Items: 50000.00
ICU income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 50000.00
ICU cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
ICU balance_sheet (annual, 2022-12-31) — Working Capital: -14629000.00
ICU income_statement (annual, 2023-12-31) — +Operating Expense: 14210000.00
ICU income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
ICU balance_sheet (annual, 2023-12-31) — Accounts Payable: 4372000.00
ICU balance_sheet (annual, 2023-12-31) — Accounts Receivable: 0.00
ICU balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 100863000.00
ICU income_statement (annual, 2023-12-31) — Basic Average Shares: 86681.00
ICU income_statement (annual, 2023-12-31) — Basic EPS: -302.60
ICU cash_flow (annual, 2023-12-31) — Beginning Cash Position: 47000.00